Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors

Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors

US Patent 11230526 · Granted Jan 25, 2022

Estimated economic value: $277,663,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Common sense reasoning for deepfake detection2025
Collections of peptides, peptide agents, and methods of use thereof2025
5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide derivatives useful as a fac2025
Pyruvate kinase activators for use in treating blood disorders2024
Immunoglobulins and uses thereof2024
Immunoglobulins and uses thereof2024
Immunoglobulins and uses thereof2024
Aza-heterobicyclic inhibitors of MAT2A and methods of use for treating cancer2024
Inhibitors of cellular metabolic processes2024
Pyruvate kinase activators for use in treating blood disorders2024
Pyruvate kinase modulators and use thereof2024
Pyridine N-oxide derivatives useful as factor XIa inhibitors2023